ArticleFrontiers in pharmacology2023

Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis.

Franziska Elena Herrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.